• Home
  • Stocks
  • Bharat Immunologicals & Biologicals Corporation Ltd.

Bharat Immunologicals & Biologicals Corporation Ltd.
Snapshot View

View in App

Prices View details >>

25.85 -0.85 ▼-3.2%

31 January 2023, 04:01:00 PM
Volume: 72,998

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bibcol.com
Market Cap 111.62 Cr.
Enterprise Value(EV) 183.62 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -2.03 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.54 Trailing Twelve Months Ending 2022-03
Book Value / Share -3.35 Trailing Twelve Months Ending 2022-03
Price to Book Value -7.71 Calculated using Price: 25.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 4.32 Cr. 43,180,000 Shares
FaceValue 10
Company Profile
The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.18%
1 Week
-8.01%
1 Month
-35.21%
3 Month
+5.51%
6 Month
-1.34%
1 Year
-46.37%
2 Year
-65.49%
5 Year
+1.97%
10 Year
+87.59%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 3.81 -16.25 16.94 -10.76 -17.00 -39.93 -158.64
Return on Capital Employed (%) 42.29 9.07 -8.52 31.11 -17.52 -10.70 -21.87 -73.05 -8.08
Return on Assets (%) 7.28 1.81 -8.50 10.80 -8.51 -7.22 -8.97 -18.41 -6.35

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 40 41 35 42 38 31 20 34 105 97
Non Curr. Liab. 3 4 1 -1 -5 -4 -8 -14 -15 -17
Curr. Liab. 48 35 30 14 13 88 101 64 101 107
Minority Int.
Equity & Liab. 91 80 66 55 45 115 113 84 192 187
Non Curr. Assets 7 7 6 8 7 16 20 50 126 129
Curr. Assets 84 74 60 47 38 99 93 34 65 58
Misc. Exp. not W/O
Total Assets 91 80 66 55 45 115 113 84 192 187

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 203 146 128 124 35 84 67 85 78 79
Other Income 6 1 1 1 1 4 1 2 1 1
Total Income 209 147 129 125 36 88 68 87 79 80
Total Expenditure -191 -143 -132 -111 -43 -93 -77 -106 -83 -89
PBIDT 18 4 -3 14 -7 -5 -9 -19 -4 -9
Interest -6 -1 -6 -4 -1 -2 -5 -5 -6 -6
Depreciation -1 -1 -1 -1 0 0 0 0 0 0
Taxation -5 -1 3 -3 4 2 4 6 1 -3
Exceptional Items
PAT 6 2 -6 7 -4 -6 -10 -18 -9 -18
Adjusted EPS 1 0 -1 2 -1 -1 -2 -4 -2 -4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 31 -12 8 -9 -17 3 -32 34 12 -42
Cash Fr. Inv. 0 0 0 1 1 1 1 1 1 1
Cash Fr. Finan. 0 -6 -1 -2 -3 -3 31 -34 -12 45
Net Change 31 -18 7 -10 -20 1 -1 1 0 3
Cash & Cash Eqvt 41 23 30 20 0 1 0 1 1 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25
Public 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 27 Dec 2022
Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd
The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on December 27 2022 with reference to Movement in Price.

The reply is awaited.
Mon, 17 Oct 2022
Board Meeting Outcome for Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended September 2022 And Limited Review Report Thereon As Per The Compliance Of LODR 2015
In pursuance of the SEBI LODR please find attached the Un-audited Quarterly Financial Results for the quarter ended September 2022 and Limited Review Report thereon as per the Compliance of LODR 2015
Tue, 11 Oct 2022
Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- SANDIP KUMAR LAL
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details >>

Tue, 31 Jan 2023
Close Crossing Last Month Low Close Crossing Last Month Low
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,034.50 -1.6%
Divi's Laboratories Ltd. 88,067.87 3,315.30 -1.5%
Cipla Ltd. 82,086.54 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. 72,004.82 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. 61,188.28 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. 51,492.78 1,521.45 -1.7%
Abbott India Ltd. 44,288.65 20,785.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.96 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.43 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 31.11 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.72 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.88 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.96 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 50.23 20,785.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.68 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.26 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 3.62 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.26 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.22 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.08 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 16.32 20,785.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,785.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,785.15 -0.9%

FAQ's On Bharat Immunologicals & Biologicals Corporation Ltd.

What is Bharat Immunological share price?
Can I buy Bharat Immunological shares now?
What is the Market Cap of Bharat Immunological?
What is the 52 Week High and Low of Bharat Immunological?
What is the trend of Bharat Immunological share price?